Skip to main content
. 2019 Jun 12;10:1353. doi: 10.3389/fimmu.2019.01353

Figure 2.

Figure 2

Detection and stability of plasma CTHRC1. (A) The specificity of the immunodetection was tested using 25 ng rhCTHRC1 spiked into the plasma (3 μL) of RA patients. Protein ladder bands (kD) are shown. (B) The resistance of the protein to proteolysis was tested with rhCTHRC1 spiked into synovial fluid (SF) or the plasma of RA patients. Final concentration of SF or plasma in the test was 12%, final amount of rhCTHRC1 loaded per lane was 15 ng. Lane 1 shows 50 ng of recombinant rhCTHRC1 protein as a reference. The Vli55 antibody was used for CTHRC1 immunodetection followed by appropriate secondary antibodies. As a positive control for digestion, incubation with trypsin was performed (lane 9). Lanes 10, 11: SF was heated for 30 min at 65°C (time, min) and then incubated with rhCTHRC1. Lanes 12, 13: SF was pre-heated for 30 min at 37°C.